Kestra Medical Technologies KMTS
NASDAQ KMTS
$28.29 -0.17 (-0.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025)

Updated

Kestra Medical Technologies' Current Deferred Revenue came in at $460,000 for fiscal Q3 2025 (quarter ended Jan 31, 2025).

Analysis

Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Kestra Medical Technologies 1.69 Bn 1.44 Bn 17.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 460,000.00
API Access

Kestra Medical Technologies Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KMTS&period=max&api_key=YOUR_API_KEY